상세 보기
자료 필터
자료유형
발행연도
1994 ~ 2036
1994 2036
키워드
언어
전체 376건 중 21번부터 30번까지의 결과를 표시합니다.
2024
Conference
Real-world safety and effectiveness of ribociclib in Korean patients with HR+/HER2-locally advanced or metastatic breast cancer
- Kim, J. H. ;
- Chang, M-C. ;
- Kim, T-H. ;
- Seo, J. H. ;
- Kim, J-J. ;
- 외 5명
- 2024-12
- 네덜란드
Article
Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents
- La, Minh Thanh ;
- Hoang, Van-Hai ;
- Sahu, Raghaba ;
- Nguyen, Cong-Truong ;
- Nam, Gibeom ;
- ... Kim, Yoon-Jae ;
- ... Seo, Jae Hong ;
- 외 5명
- 2024-10
- European Journal of Medicinal Chemistry
- Elsevier BV
Article
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study
- Park, Min Ho ;
- Seo, Jae Hong ;
- Park, Jung Ho ;
- Seong, Min-Ki ;
- Park, Keon Uk ;
- 외 16명
- 2024-04
- Expert Opinion on Biological Therapy
- Ashley Publications Ltd.
Article
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer
- Tolaney, Sara M. ;
- Guarneri, Valentina ;
- Seo, Jae Hong ;
- Cruz, Josefina ;
- Abreu, Miguel Henriques ;
- 외 11명
- 2024-03
- European Journal of Cancer
- Pergamon Press Ltd.
Article
The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer
- Park, Minsu ;
- Jung, Eunsun ;
- Park, Jung Min ;
- Park, Soeun ;
- Ko, Dongmi ;
- ... Nam, Kee Dal ;
- ... Kim, Yoon-Jae ;
- ... Kim, Ji Young ;
- ... Seo, Jae Hong ;
- 외 11명
- 2024-03
- Theranostics
- Ivyspring International Publisher
Article
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial
- Huang, Liang ;
- Pang, Da ;
- Yang, Hongjian ;
- Li, Wei ;
- Wang, Shusen ;
- ... Seo, Jae Hong ;
- 외 18명
- 2024-03
- Nature Communications
- Nature Publishing Group